Novel dosage and formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/14 (2006.01) A61K 9/72 (2006.01) A61K 31/46 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2716723

A pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 200 micrograms aclidinium bromide.

La présente invention concerne une composition pharmaceutique pour inhalation. Ladite composition contient de laclidinium sous la forme dune poudre sèche dun sel pharmaceutiquement acceptable, mélangé à un vecteur de poudre sèche pharmaceutiquement acceptable, qui fournit une dose nominale daclidinium équivalente à environ 200 microgrammes de bromure daclidinium.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel dosage and formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel dosage and formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel dosage and formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1670255

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.